Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

Bullboard (TSXV:CZO)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Post by prophetoffactzon Feb 26, 2024 11:15am

Chewy Sports Bar with Avenanthramide - exercise inflammation

The chewy bar could be a new franchise for CZO. It could be a delivery format for a range of bioactives from beta glucan, to avenanthramide(exercise inflammation), to PGX-YBG/CoQ10(energy bar).   ...more  
53
Comment by prophetoffactzon Feb 26, 2024 11:11am

RE:RE:Proxy Advisors

"Come Boaz, be fair... the market for jamming one's face full of gelatin is expected to be >$850 million in 2032!!!" It was recently approved by Heath Canada. Beta glucan is the ...more  
55
Discussion
Comment by prophetoffactzon Feb 26, 2024 11:08am

RE:RE:Parasitic merger? No thanks

Does a 'no' vote derail the access to capital the merger provides to accelerate CZO's plans for significant growth given the many opportunities in Friday's news release. Would it cause ...more  
39
Discussion
Comment by PBaelishhon Feb 26, 2024 11:06am

RE:Proxy Advisors

Come Boaz, be fair... the market for jamming one's face full of gelatin is expected to be >$850 million in 2032!!! It was in the press release... The Sage of Sherbrooke, Gagnon, said so ...more  
39
Discussion
Comment by prophetoffactzon Feb 26, 2024 10:16am

RE:Proxy Advisors

"I love the dropping of the oat chewy thing in the NR." It was recently approved by Heath Canada. You've moaned about the beta glucan pill clinical trial. This may be the result.   ...more  
40
Discussion
Comment by Apostataon Feb 26, 2024 10:08am

RE:Parasitic merger? No thanks

Arguably the only people who want this parasitic merger are the more desperate shareholders of AEZS, who understand that if the merger is approved they get to increase their cash burn runway at CZO ...more  
39
Discussion
Post by boazklinghornon Feb 26, 2024 10:05am

Proxy Advisors

Here is a link for anyone who thinks ISS is a useful impartial gauge of ther merits of any particular deal. https://www.sec.gov/comments/4-725/4725-4549663-176173.pdf More importtantly the one thing ...more  
80
Discussion
Comment by prophetoffactzon Feb 26, 2024 10:03am

RE:RE:RE:New 52-week high for S&P Biotech ETF

Breakout... 97.02+2.27 (+2.40%) As of 09:35AM EST. Market open.
32
Discussion
Comment by prophetoffactzon Feb 26, 2024 10:00am

RE:RE:New 52-week high for S&P Biotech ETF

At the bottom of the biotech market. The market is up a stunning 50% since the bottom and assets are valued in the context of the market and the other options available. We are in a different world ...more  
28
Discussion
Post by fossi_2002on Feb 26, 2024 9:55am

It should be illegal to not disclose that ISS is paid by CZO

If what you write is correct, Icsfa, then that's just a shame. But apparently all that matters is that Ronnie is thrilled. The proof of performance that a good board member should provide no ...more  
65
Comment by prophetoffactzon Feb 26, 2024 9:50am

RE:New 52-week high for S&P Biotech ETF

Last time the S&P Biotech ETF was trading at this level looks about April 4, 2022 judging by the Stockhouse chart. AEZS was US$9.34 or about 400% higher. It's a different situation now but ...more  
37
Discussion
Comment by lscfaon Feb 26, 2024 9:44am

RE:New 52-week high for S&P Biotech ETF

Wainwright did not cut AEZS target price from $28 to $15 based on valuation multiples of the biotech sector. It slashed the target due to co. specific fundamentals.
25
Discussion
Post by prophetoffactzon Feb 26, 2024 9:39am

New 52-week high for S&P Biotech ETF

96.18+1.43 (+1.51%) As of 09:35AM EST. Market open. Up 50% in four months. Gilles did his part to scoop biotech assets up below cash after the worst biotech bear market in history. We may ...more  
49
Discussion
Comment by Possibleidiot01on Feb 26, 2024 9:37am

RE:New Press Release - Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

This is a chilling sentence . "“On balance, the deal has strong strategic merit, third party solicitation was unable to generate any other actionable proposals, and governance conflicts appear ...more  
46
Discussion
Post by lscfaon Feb 26, 2024 9:25am

Last AEZS rollback mid 2022

Not approved at June mtg. Meeting adjourned until July. Barely passed with 67.35% (2/3 approval was needed)
53
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next